On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio
Artificial intelligence (AI) and omnichannel have come to seem mere buzzwords these days in the life sciences – everyone is talking about them, everyone wants to use them.
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho
In today's fast-paced digital world delivering relevant, valuable content that resonates with your target audience is more important than ever.
What does it take to establish new treatments for rare diseases?
Editor's Picks
